The European Commission’s Innovation Radar analysed three innovations developed in the PRIMAGE project by Fundacion Para La Investigacion Del Hospital Universitario La Fe De La Comunidad Valenciana (HULAFE), Universita di Pisa (UNIPI), Universidad de Zaragoza (UNZAR), Chemotargets (CHMT), and Universita di Bologna (UNIBO).
The Innovation Radar platform builds on the information and data gathered by independent experts involved in reviewing ongoing research and innovation projects funded by the European Commission. These experts also provided an independent view regarding the innovations in the projects and their market potential. The aim is to make information about EU-funded innovations from high-quality projects visible and accessible to the public via the EU’s Innovation Radar platform. This will show citizens the many excellent technological and scientific advances being delivered by researchers and innovators around Europe, funded on their behalf by the European Commission. This initiative has the support of EU Members States and, to date, Ministers from 23 countries have signed the Innovation Radar declaration confirming their support for this initiative. The inclusion in this initiative could open up new opportunities to partner with a business or academic organisations and trigger interest from potential customers or investors in the innovation. Above all, it will demonstrate to a global audience the innovative work that the project is actively delivering.
You can read the analysis via these links:
- (HULAFE & UNIPI) Computational tools for the processing and analysis of imaging data
- (HULAFE) Platform for the collection, exploration and analysis of clinical data
- (UNIZAR, CHMT, UNIBO) Multiscale modelling of tumour growth and progression